212 related articles for article (PubMed ID: 11160174)
1. Partitioned prostate cancer prevalence estimates: an informative measure of the disease burden.
Merrill RM
J Epidemiol Community Health; 2001 Mar; 55(3):191-7. PubMed ID: 11160174
[TBL] [Abstract][Full Text] [Related]
2. Measuring the public health burden of cancer in the United States through lifetime and age-conditional risk estimates.
Merrill RM; Weed DL
Ann Epidemiol; 2001 Nov; 11(8):547-53. PubMed ID: 11709274
[TBL] [Abstract][Full Text] [Related]
3. Racial disparities in prostate cancer incidence rates by census division in the United States, 1999-2008.
Cook MB; Rosenberg PS; McCarty FA; Wu M; King J; Eheman C; Anderson WF
Prostate; 2015 May; 75(7):758-63. PubMed ID: 25619191
[TBL] [Abstract][Full Text] [Related]
4. Ultraviolet index and racial differences in prostate cancer incidence and mortality.
Taksler GB; Cutler DM; Giovannucci E; Smith MR; Keating NL
Cancer; 2013 Sep; 119(17):3195-203. PubMed ID: 23744754
[TBL] [Abstract][Full Text] [Related]
5. Trends in the Incidence of Fatal Prostate Cancer in the United States by Race.
Kelly SP; Rosenberg PS; Anderson WF; Andreotti G; Younes N; Cleary SD; Cook MB
Eur Urol; 2017 Feb; 71(2):195-201. PubMed ID: 27476048
[TBL] [Abstract][Full Text] [Related]
6. Evidence supports a faster growth rate and/or earlier transformation to clinically significant prostate cancer in black than in white American men, and influences racial progression and mortality disparity.
Powell IJ; Bock CH; Ruterbusch JJ; Sakr W
J Urol; 2010 May; 183(5):1792-6. PubMed ID: 20299055
[TBL] [Abstract][Full Text] [Related]
7. Geographic Distribution of Racial Differences in Prostate Cancer Mortality.
Fletcher SA; Marchese M; Cole AP; Mahal BA; Friedlander DF; Krimphove M; Kilbridge KL; Lipsitz SR; Nguyen PL; Choueiri TK; Kibel AS; Trinh QD
JAMA Netw Open; 2020 Mar; 3(3):e201839. PubMed ID: 32232449
[TBL] [Abstract][Full Text] [Related]
8. Cancer prevalence estimates based on tumour registry data in the Surveillance, Epidemiology, and End Results (SEER) Program.
Merrill RM; Capocaccia R; Feuer EJ; Mariotto A
Int J Epidemiol; 2000 Apr; 29(2):197-207. PubMed ID: 10817114
[TBL] [Abstract][Full Text] [Related]
9. Prevalence-corrected prostate cancer incidence rates and trends.
Merrill RM; Morris MK
Am J Epidemiol; 2002 Jan; 155(2):148-52. PubMed ID: 11790678
[TBL] [Abstract][Full Text] [Related]
10. Racial Disparities in the Presentation, Early Definitive Surgical Treatment, and Mortality Among Men Diagnosed with Poorly Differentiated/Undifferentiated Non-metastatic Prostate Cancer in the USA.
Lediju O; Ikuemonisan J; Salami SS; Adejoro O
J Racial Ethn Health Disparities; 2019 Apr; 6(2):401-408. PubMed ID: 30506310
[TBL] [Abstract][Full Text] [Related]
11. Early estimates of cancer incidence for 2015: Expanding to include estimates for white and black races.
Lewis DR; Chen HS; Cockburn MG; Wu XC; Stroup AM; Midthune DN; Zou Z; Krapcho MF; Miller DG; Feuer EJ
Cancer; 2018 May; 124(10):2192-2204. PubMed ID: 29509274
[TBL] [Abstract][Full Text] [Related]
12. Trends in prostate cancer mortality among black men and white men in the United States.
Chu KC; Tarone RE; Freeman HP
Cancer; 2003 Mar; 97(6):1507-16. PubMed ID: 12627516
[TBL] [Abstract][Full Text] [Related]
13. Racial disparities in late-stage prostate cancer: a SEER analysis 2005-2015.
Rodriguez S; Sparks AD; Zhou H; Amdu RL; Lin J
Can J Urol; 2019 Oct; 26(5):9946-9951. PubMed ID: 31629445
[TBL] [Abstract][Full Text] [Related]
14. Annual Report to the Nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer.
Edwards BK; Noone AM; Mariotto AB; Simard EP; Boscoe FP; Henley SJ; Jemal A; Cho H; Anderson RN; Kohler BA; Eheman CR; Ward EM
Cancer; 2014 May; 120(9):1290-314. PubMed ID: 24343171
[TBL] [Abstract][Full Text] [Related]
15. Prostate cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study.
Steele CB; Li J; Huang B; Weir HK
Cancer; 2017 Dec; 123 Suppl 24(Suppl 24):5160-5177. PubMed ID: 29205313
[TBL] [Abstract][Full Text] [Related]
16. Removal of the financial barrier to health care: does it impact on prostate cancer at presentation and survival? A comparative study between black and white men in a Veterans Affairs system.
Powell IJ; Schwartz K; Hussain M
Urology; 1995 Dec; 46(6):825-30. PubMed ID: 7502424
[TBL] [Abstract][Full Text] [Related]
17. Differences in the prevalence of modifiable risk and protective factors for prostate cancer by race and ethnicity in the National Health and Nutrition Examination Survey.
Defever K; Platz EA; Lopez DS; Mondul AM
Cancer Causes Control; 2020 Sep; 31(9):851-860. PubMed ID: 32666408
[TBL] [Abstract][Full Text] [Related]
18. Black-white differences in survival from late-stage prostate cancer.
Polednak AP
Ethn Dis; 2003; 13(2):220-5. PubMed ID: 12785419
[TBL] [Abstract][Full Text] [Related]
19. The lifetime risk of developing prostate cancer in white and black men.
Merrill RM; Weed DL; Feuer EJ
Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):763-8. PubMed ID: 9332756
[TBL] [Abstract][Full Text] [Related]
20. Asymptomatic incidence and duration of prostate cancer.
Etzioni R; Cha R; Feuer EJ; Davidov O
Am J Epidemiol; 1998 Oct; 148(8):775-85. PubMed ID: 9786232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
